Europe, Middle East & India OTC Multivitamins And Minerals Supplements Market Size, Share & Trends Analysis Report By Ingredient, By Form, By Functionality, By End-use, By Region, And Segment Forecasts, 2025 - 2030
This report can be delivered to the clients within 3 Business Days
Europe, Middle East & India OTC Multivitamins & Minerals Supplements Market Growth & Trends
The Europe, Middle East and India OTC multivitamins and minerals supplements market size is expected treach USD 20.64 billion by 2030, according ta new report by Grand View Research, Inc. It is expected texpand at a CAGR of 11.9% from 2025 t2030. Rising expenditure by sports nutrition market players on in-store promotions and advertising features is expected tpromote the accessibility and popularity of multivitamins and minerals supplements over the next eight years in the concerned regions.
Growing consumer awareness regarding the benefits of a nutritious and healthy diet and overall wellness has led tthe robust growth of the OTC multivitamin and minerals supplements industry. Gym workouts and other fitness activities are becoming a part of the daily routine of the younger generation across these countries, which demand necessary health supplements, thereby helping the industry grow. These supplements are believed timpart exceptional health benefits necessary for maintaining good vision, normal appetite, healthy skin, red blood cell formation, and nervous system.
Increasing geriatric population, food innovation, changing lifestyle, rising healthcare costs, medical discoveries, and suppositions regarding the higher prices of the products have facilitated the demand for OTC multivitamins and minerals supplements. Moreover, the consumption of these supplements can reduce total and low-density lipoprotein (LDL) cholesterol, thus reducing the problems related tcoronary heart disease.
The outbreak of the COVID-19 pandemic has created strong awareness regarding the importance of immunity and immunity-boosting products, which is anticipated tfuel the industry growth even further. The rising availability of the product in the form of gummies and lollipop induced with novel flavors is projected tdrive the demand for multivitamins and mineral supplements among children.
Europe, Middle East And India (EMEI) OTC Multivitamins & Minerals Supplements Market Report Highlights
Europe, Middle East & India OTC Multivitamins & Minerals Supplements Market Growth & Trends
The Europe, Middle East and India OTC multivitamins and minerals supplements market size is expected treach USD 20.64 billion by 2030, according ta new report by Grand View Research, Inc. It is expected texpand at a CAGR of 11.9% from 2025 t2030. Rising expenditure by sports nutrition market players on in-store promotions and advertising features is expected tpromote the accessibility and popularity of multivitamins and minerals supplements over the next eight years in the concerned regions.
Growing consumer awareness regarding the benefits of a nutritious and healthy diet and overall wellness has led tthe robust growth of the OTC multivitamin and minerals supplements industry. Gym workouts and other fitness activities are becoming a part of the daily routine of the younger generation across these countries, which demand necessary health supplements, thereby helping the industry grow. These supplements are believed timpart exceptional health benefits necessary for maintaining good vision, normal appetite, healthy skin, red blood cell formation, and nervous system.
Increasing geriatric population, food innovation, changing lifestyle, rising healthcare costs, medical discoveries, and suppositions regarding the higher prices of the products have facilitated the demand for OTC multivitamins and minerals supplements. Moreover, the consumption of these supplements can reduce total and low-density lipoprotein (LDL) cholesterol, thus reducing the problems related tcoronary heart disease.
The outbreak of the COVID-19 pandemic has created strong awareness regarding the importance of immunity and immunity-boosting products, which is anticipated tfuel the industry growth even further. The rising availability of the product in the form of gummies and lollipop induced with novel flavors is projected tdrive the demand for multivitamins and mineral supplements among children.
Europe, Middle East And India (EMEI) OTC Multivitamins & Minerals Supplements Market Report Highlights
- Based on ingredients, multivitamins dominated the market with a revenue share of 78.5% in 2024. This is attributed tthe growing cases of vitamin deficiencies in numerous regions, rapid lifestyle changes, and increasing urbanization
- OTC multivitamins and mineral supplements tablets held the largest revenue share of the Europe, Middle East & India OTC multivitamins & minerals supplements industry in 2024.
- The adults segment held the largest revenue share of the Europe, Middle East & India OTC multivitamins and minerals supplements market in 2024.
- Mergers & acquisitions, expansions, and joint ventures are a few strategies implemented by the market players. For instance, in August 2020, OptiBiotix, a U.K.-based nutritional ingredients manufacturer, launched a functional fiber and mineral blend called WellBiome. The introduction of this mineral blend comprising of fructooligosaccharides, glucomannan, and chromium was aimed at expanding the company’s health and wellness portfolio
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources & Third-Party Perspectives
1.3.4. Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Data Visualization
1.6. Data Validation & Publishing
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
CHAPTER 3. EUROPE, MIDDLE EAST & INDIA OTC MULTIVITAMINS & MINERALS SUPPLEMENTS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related Market Outlook
3.2. Industry Value Chain Analysis
3.2.1. Profit Margin Analysis (Industry-level)
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.3.3. Market Opportunities
3.3.4. Market Challenges
3.4. Industry Analysis Tools
3.4.1. Porter’s Five Forces Analysis
3.5. Market Entry Strategies
CHAPTER 4. CONSUMER BEHAVIOR ANALYSIS
4.1. Demographic Analysis
4.2. Consumer Trends and Preferences
4.3. Factors Affecting Buying Decision
4.4. Consumer Ingredient Adoption
4.5. Observations & Recommendations
CHAPTER 5. EUROPE, MIDDLE EAST & INDIA OTC MULTIVITAMINS & MINERALS SUPPLEMENTS MARKET: INGREDIENT ESTIMATES & TREND ANALYSIS
5.1. Europe, Middle East & India OTC Multivitamins & Minerals Supplements OTC multivitamins & minerals supplements Market, By Ingredient: Key Takeaways
5.2. Ingredient Movement Analysis & Market Share, 2024 & 2030
5.3. Market Estimates & Forecasts, By Ingredient, 2018 - 2030 (USD Million)
5.3.1. Multivitamins
5.3.1.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.1.2. Vitamin A
5.3.1.2.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.1.3. Vitamin C
5.3.1.3.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.1.4. Vitamin D
5.3.1.4.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.1.5. Vitamin E
5.3.1.5.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.1.6. Vitamin K
5.3.1.6.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.1.7. Vitamin B
5.3.1.7.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.1.7.2. Thiamine
5.3.1.7.2.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.1.7.3. Riboflavin
5.3.1.7.3.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.1.7.4. Niacin
5.3.1.7.4.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.1.7.5. Pantothenic Acid
5.3.1.7.5.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.1.7.6. Biotin
5.3.1.7.6.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.1.7.7. B6
5.3.1.7.7.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.1.7.8. B12
5.3.1.7.8.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.1.7.9. Folate
5.3.1.7.9.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.2. Minerals
5.3.2.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.2.2. Iodine
5.3.2.2.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.2.3. Calcium
5.3.2.3.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.2.4. Magnesium
5.3.2.4.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.2.5. Potassium
5.3.2.5.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.2.6. Selenium
5.3.2.6.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.2.7. Manganese
5.3.2.7.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.2.8. Molybdenum
5.3.2.8.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.2.9. Phosphorus
5.3.2.9.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.2.10. Sodium
5.3.2.10.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.2.11. Chloride
5.3.2.11.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.2.12. Zinc
5.3.2.12.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.2.13. Iron
5.3.2.13.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.2.14. Copper
5.3.2.14.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
CHAPTER 6. EUROPE, MIDDLE EAST & INDIA OTC MULTIVITAMINS & MINERALS SUPPLEMENTS MARKET: FORM ESTIMATES & TREND ANALYSIS
6.1. Europe, Middle East & India OTC Multivitamins & Minerals Supplements Market, By Form: Key Takeaways
6.2. Form Movement Analysis & Market Share, 2024 & 2030
6.3. Market Estimates & Forecasts, By Form, 2018 - 2030 (USD Million)
6.3.1. Powder
6.3.1.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
6.3.2. Tablets
6.3.2.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
6.3.3. Capsules
6.3.3.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
6.3.4. Softgels
6.3.4.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
6.3.5. Gummies
6.3.5.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
6.3.6. Liquid
6.3.6.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
6.3.7. Others
6.3.7.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
CHAPTER 7. EUROPE, MIDDLE EAST & INDIA OTC MULTIVITAMINS & MINERALS SUPPLEMENTS MARKET: FUNCTIONALITY ESTIMATES & TREND ANALYSIS
7.1. Europe, Middle East & India OTC Multivitamins & Minerals Supplements Market, By Functionality: Key Takeaways
7.2. Functionality Movement Analysis & Market Share, 2024 & 2030
7.3. Market Estimates & Forecasts, by Functionality, 2018 - 2030 (USD Million)
7.3.1. Energy & Weight Management
7.3.1.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
7.3.2. General Health
7.3.2.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
7.3.3. Bone & Joint Health
7.3.3.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
7.3.4. Gastrointestinal Health
7.3.4.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
7.3.5. Immunity
7.3.5.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
7.3.6. Cardiac Health
7.3.6.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
7.3.7. Diabetes
7.3.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.3.8. Anti-Cancer
7.3.8.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
7.3.9. Others
7.3.9.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
CHAPTER 8. EUROPE, MIDDLE EAST & INDIA OTC MULTIVITAMINS & MINERALS SUPPLEMENTS MARKET: END USE ESTIMATES & TREND ANALYSIS
8.1. Europe, Middle East & India OTC Multivitamins & Minerals Supplements Market, By End Use: Key Takeaways
8.2. End Use Movement Analysis & Market Share, 2024 & 2030
8.3. Market Estimates & Forecasts, By End Use, 2018 - 2030 (USD Million)
8.3.1. Adults
8.3.1.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.2. Geriatric
8.3.2.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.3. Pregnant Women
8.3.3.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.4. Children
8.3.4.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.5. Infants
8.3.5.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
CHAPTER 9. EUROPE, MIDDLE EAST & INDIA OTC MULTIVITAMINS & MINERALS SUPPLEMENTS : REGIONAL ESTIMATES & TREND ANALYSIS
9.1. Europe, Middle East & India OTC Multivitamins & Minerals Supplements Market: Regional Outlook
9.2. Regional Marketplaces: Key Takeaways
9.3. Market Estimates & Forecasts, by Region, 2018 - 2030 (USD Million)
9.3.1. Europe
9.3.1.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
9.3.1.2. Germany
9.3.1.2.1. Key Country Dynamics
9.3.1.2.2. Market Estimates and Forecast, 2018 - 2030 (USD Million)
9.3.1.3. U.K.
9.3.1.3.1. Key Country Dynamics
9.3.1.3.2. Market Estimates and Forecast, 2018 - 2030 (USD Million)
9.3.1.4. France
9.3.1.4.1. Key Country Dynamics
9.3.1.4.2. Market Estimates and Forecast, 2018 - 2030 (USD Million)
9.3.1.5. Italy
9.3.1.5.1. Key Country Dynamics
9.3.1.5.2. Market Estimates and Forecast, 2018 - 2030 (USD Million)
9.3.1.6. Spain
9.3.1.6.1. Key Country Dynamics
9.3.1.6.2. Market Estimates and Forecast, 2018 - 2030 (USD Million)
9.3.1.7. Netherlands
9.3.1.7.1. Key Country Dynamics
9.3.1.7.2. Market Estimates and Forecast, 2018 - 2030 (USD Million)
9.3.1.8. Switzerland
9.3.1.8.1. Key Country Dynamics
9.3.1.8.2. Market Estimates and Forecast, 2018 - 2030 (USD Million)
9.3.1.9. Austria
9.3.1.9.1. Key Country Dynamics
9.3.1.9.2. Market Estimates and Forecast, 2018 - 2030 (USD Million)
9.3.2. Middle East
9.3.2.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
9.3.2.2. Saudi Arabia
9.3.2.2.1. Key Country Dynamics
9.3.2.2.2. Market Estimates and Forecast, 2018 - 2030 (USD Million)
9.3.2.3. Turkey
9.3.2.3.1. Key Country Dynamics
9.3.2.3.2. Market Estimates and Forecast, 2018 - 2030 (USD Million)
9.3.2.4. Egypt
9.3.2.4.1. Key Country Dynamics
9.3.2.4.2. Market Estimates and Forecast, 2018 - 2030 (USD Million)
9.3.2.5. UAE
9.3.2.5.1. Key Country Dynamics
9.3.2.5.2. Market Estimates and Forecast, 2018 - 2030 (USD Million)
9.3.2.6. Bahrain
9.3.2.6.1. Key Country Dynamics
9.3.2.6.2. Market Estimates and Forecast, 2018 - 2030 (USD Million)
9.3.2.7. Oman
9.3.2.7.1. Key Country Dynamics
9.3.2.7.2. Market Estimates and Forecast, 2018 - 2030 (USD Million)
9.3.2.8. Kuwait
9.3.2.8.1. Key Country Dynamics
9.3.2.8.2. Market Estimates and Forecast, 2018 - 2030 (USD Million)
9.3.3. India
9.3.3.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
CHAPTER 10. EUROPE, MIDDLE EAST & INDIA OTC MULTIVITAMINS & MINERALS SUPPLEMENTS MARKET: COMPETITIVE ANALYSIS
10.1. Recent Developments & Impact Analysis, By Key Market Participants
10.2. Company Categorization
10.3. Participant’s Overview
10.4. Financial Performance
10.5. Product Benchmarking
10.6. Company Market Share Analysis, 2024 (%)
10.7. Company Heat Map Analysis
10.8. Strategy Mapping
10.9. Company Profiles
10.9.1. Amway Corp.
10.9.1.1. Company Overview
10.9.1.2. Financial Performance
10.9.1.3. Product Portfolios
10.9.1.4. Strategic Initiatives
10.9.2. Abbott
10.9.2.1. Company Overview
10.9.2.2. Financial Performance
10.9.2.3. Product Portfolios
10.9.2.4. Strategic Initiatives
10.9.3. Bayer AG
10.9.3.1. Company Overview
10.9.3.2. Financial Performance
10.9.3.3. Product Portfolios
10.9.3.4. Strategic Initiatives
10.9.4. Glanbia PLC
10.9.4.1. Company Overview
10.9.4.2. Financial Performance
10.9.4.3. Product Portfolios
10.9.4.4. Strategic Initiatives
10.9.5. GSK plc.
10.9.5.1. Company Overview
10.9.5.2. Financial Performance
10.9.5.3. Product Portfolios
10.9.5.4. Strategic Initiatives
10.9.6. Herbalife International of America, Inc.
10.9.6.1. Company Overview
10.9.6.2. Financial Performance
10.9.6.3. Product Portfolios
10.9.6.4. Strategic Initiatives
10.9.7. NU SKIN
10.9.7.1. Company Overview
10.9.7.2. Financial Performance
10.9.7.3. Product Portfolios
10.9.7.4. Strategic Initiatives
10.9.8. NOW Foods
10.9.8.1. Company Overview
10.9.8.2. Financial Performance
10.9.8.3. Product Portfolios
10.9.8.4. Strategic Initiatives
10.9.9. Bionova
10.9.9.1. Company Overview
10.9.9.2. Financial Performance
10.9.9.3. Product Portfolios
10.9.9.4. Strategic Initiatives
10.9.10. Bright Lifecare Private Limited
10.9.10.1. Company Overview
10.9.10.2. Financial Performance
10.9.10.3. Product Portfolios
10.9.10.4. Strategic Initiatives
10.9.11. Sun Pharmaceutical Industries Ltd.
10.9.11.1. Company Overview
10.9.11.2. Financial Performance
10.9.11.3. Product Portfolios
10.9.11.4. Strategic Initiatives
10.9.12. Nature's Sunshine Products, Inc.
10.9.12.1. Company Overview
10.9.12.2. Financial Performance
10.9.12.3. Product Portfolios
10.9.12.4. Strategic Initiatives
10.9.13. Nutra Essential OTC (Farmalider)
10.9.13.1. Company Overview
10.9.13.2. Financial Performance
10.9.13.3. Product Portfolios
10.9.13.4. Strategic Initiatives
10.9.14. Nature's Bounty
10.9.14.1. Company Overview
10.9.14.2. Financial Performance
10.9.14.3. Product Portfolios
10.9.14.4. Strategic Initiatives
10.9.15. Arkopharma
10.9.15.1. Company Overview
10.9.15.2. Financial Performance
10.9.15.3. Product Portfolios
10.9.15.4. Strategic Initiatives
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources & Third-Party Perspectives
1.3.4. Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Data Visualization
1.6. Data Validation & Publishing
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
CHAPTER 3. EUROPE, MIDDLE EAST & INDIA OTC MULTIVITAMINS & MINERALS SUPPLEMENTS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related Market Outlook
3.2. Industry Value Chain Analysis
3.2.1. Profit Margin Analysis (Industry-level)
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.3.3. Market Opportunities
3.3.4. Market Challenges
3.4. Industry Analysis Tools
3.4.1. Porter’s Five Forces Analysis
3.5. Market Entry Strategies
CHAPTER 4. CONSUMER BEHAVIOR ANALYSIS
4.1. Demographic Analysis
4.2. Consumer Trends and Preferences
4.3. Factors Affecting Buying Decision
4.4. Consumer Ingredient Adoption
4.5. Observations & Recommendations
CHAPTER 5. EUROPE, MIDDLE EAST & INDIA OTC MULTIVITAMINS & MINERALS SUPPLEMENTS MARKET: INGREDIENT ESTIMATES & TREND ANALYSIS
5.1. Europe, Middle East & India OTC Multivitamins & Minerals Supplements OTC multivitamins & minerals supplements Market, By Ingredient: Key Takeaways
5.2. Ingredient Movement Analysis & Market Share, 2024 & 2030
5.3. Market Estimates & Forecasts, By Ingredient, 2018 - 2030 (USD Million)
5.3.1. Multivitamins
5.3.1.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.1.2. Vitamin A
5.3.1.2.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.1.3. Vitamin C
5.3.1.3.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.1.4. Vitamin D
5.3.1.4.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.1.5. Vitamin E
5.3.1.5.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.1.6. Vitamin K
5.3.1.6.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.1.7. Vitamin B
5.3.1.7.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.1.7.2. Thiamine
5.3.1.7.2.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.1.7.3. Riboflavin
5.3.1.7.3.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.1.7.4. Niacin
5.3.1.7.4.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.1.7.5. Pantothenic Acid
5.3.1.7.5.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.1.7.6. Biotin
5.3.1.7.6.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.1.7.7. B6
5.3.1.7.7.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.1.7.8. B12
5.3.1.7.8.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.1.7.9. Folate
5.3.1.7.9.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.2. Minerals
5.3.2.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.2.2. Iodine
5.3.2.2.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.2.3. Calcium
5.3.2.3.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.2.4. Magnesium
5.3.2.4.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.2.5. Potassium
5.3.2.5.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.2.6. Selenium
5.3.2.6.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.2.7. Manganese
5.3.2.7.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.2.8. Molybdenum
5.3.2.8.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.2.9. Phosphorus
5.3.2.9.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.2.10. Sodium
5.3.2.10.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.2.11. Chloride
5.3.2.11.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.2.12. Zinc
5.3.2.12.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.2.13. Iron
5.3.2.13.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3.2.14. Copper
5.3.2.14.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
CHAPTER 6. EUROPE, MIDDLE EAST & INDIA OTC MULTIVITAMINS & MINERALS SUPPLEMENTS MARKET: FORM ESTIMATES & TREND ANALYSIS
6.1. Europe, Middle East & India OTC Multivitamins & Minerals Supplements Market, By Form: Key Takeaways
6.2. Form Movement Analysis & Market Share, 2024 & 2030
6.3. Market Estimates & Forecasts, By Form, 2018 - 2030 (USD Million)
6.3.1. Powder
6.3.1.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
6.3.2. Tablets
6.3.2.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
6.3.3. Capsules
6.3.3.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
6.3.4. Softgels
6.3.4.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
6.3.5. Gummies
6.3.5.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
6.3.6. Liquid
6.3.6.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
6.3.7. Others
6.3.7.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
CHAPTER 7. EUROPE, MIDDLE EAST & INDIA OTC MULTIVITAMINS & MINERALS SUPPLEMENTS MARKET: FUNCTIONALITY ESTIMATES & TREND ANALYSIS
7.1. Europe, Middle East & India OTC Multivitamins & Minerals Supplements Market, By Functionality: Key Takeaways
7.2. Functionality Movement Analysis & Market Share, 2024 & 2030
7.3. Market Estimates & Forecasts, by Functionality, 2018 - 2030 (USD Million)
7.3.1. Energy & Weight Management
7.3.1.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
7.3.2. General Health
7.3.2.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
7.3.3. Bone & Joint Health
7.3.3.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
7.3.4. Gastrointestinal Health
7.3.4.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
7.3.5. Immunity
7.3.5.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
7.3.6. Cardiac Health
7.3.6.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
7.3.7. Diabetes
7.3.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.3.8. Anti-Cancer
7.3.8.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
7.3.9. Others
7.3.9.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
CHAPTER 8. EUROPE, MIDDLE EAST & INDIA OTC MULTIVITAMINS & MINERALS SUPPLEMENTS MARKET: END USE ESTIMATES & TREND ANALYSIS
8.1. Europe, Middle East & India OTC Multivitamins & Minerals Supplements Market, By End Use: Key Takeaways
8.2. End Use Movement Analysis & Market Share, 2024 & 2030
8.3. Market Estimates & Forecasts, By End Use, 2018 - 2030 (USD Million)
8.3.1. Adults
8.3.1.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.2. Geriatric
8.3.2.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.3. Pregnant Women
8.3.3.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.4. Children
8.3.4.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.5. Infants
8.3.5.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
CHAPTER 9. EUROPE, MIDDLE EAST & INDIA OTC MULTIVITAMINS & MINERALS SUPPLEMENTS : REGIONAL ESTIMATES & TREND ANALYSIS
9.1. Europe, Middle East & India OTC Multivitamins & Minerals Supplements Market: Regional Outlook
9.2. Regional Marketplaces: Key Takeaways
9.3. Market Estimates & Forecasts, by Region, 2018 - 2030 (USD Million)
9.3.1. Europe
9.3.1.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
9.3.1.2. Germany
9.3.1.2.1. Key Country Dynamics
9.3.1.2.2. Market Estimates and Forecast, 2018 - 2030 (USD Million)
9.3.1.3. U.K.
9.3.1.3.1. Key Country Dynamics
9.3.1.3.2. Market Estimates and Forecast, 2018 - 2030 (USD Million)
9.3.1.4. France
9.3.1.4.1. Key Country Dynamics
9.3.1.4.2. Market Estimates and Forecast, 2018 - 2030 (USD Million)
9.3.1.5. Italy
9.3.1.5.1. Key Country Dynamics
9.3.1.5.2. Market Estimates and Forecast, 2018 - 2030 (USD Million)
9.3.1.6. Spain
9.3.1.6.1. Key Country Dynamics
9.3.1.6.2. Market Estimates and Forecast, 2018 - 2030 (USD Million)
9.3.1.7. Netherlands
9.3.1.7.1. Key Country Dynamics
9.3.1.7.2. Market Estimates and Forecast, 2018 - 2030 (USD Million)
9.3.1.8. Switzerland
9.3.1.8.1. Key Country Dynamics
9.3.1.8.2. Market Estimates and Forecast, 2018 - 2030 (USD Million)
9.3.1.9. Austria
9.3.1.9.1. Key Country Dynamics
9.3.1.9.2. Market Estimates and Forecast, 2018 - 2030 (USD Million)
9.3.2. Middle East
9.3.2.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
9.3.2.2. Saudi Arabia
9.3.2.2.1. Key Country Dynamics
9.3.2.2.2. Market Estimates and Forecast, 2018 - 2030 (USD Million)
9.3.2.3. Turkey
9.3.2.3.1. Key Country Dynamics
9.3.2.3.2. Market Estimates and Forecast, 2018 - 2030 (USD Million)
9.3.2.4. Egypt
9.3.2.4.1. Key Country Dynamics
9.3.2.4.2. Market Estimates and Forecast, 2018 - 2030 (USD Million)
9.3.2.5. UAE
9.3.2.5.1. Key Country Dynamics
9.3.2.5.2. Market Estimates and Forecast, 2018 - 2030 (USD Million)
9.3.2.6. Bahrain
9.3.2.6.1. Key Country Dynamics
9.3.2.6.2. Market Estimates and Forecast, 2018 - 2030 (USD Million)
9.3.2.7. Oman
9.3.2.7.1. Key Country Dynamics
9.3.2.7.2. Market Estimates and Forecast, 2018 - 2030 (USD Million)
9.3.2.8. Kuwait
9.3.2.8.1. Key Country Dynamics
9.3.2.8.2. Market Estimates and Forecast, 2018 - 2030 (USD Million)
9.3.3. India
9.3.3.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
CHAPTER 10. EUROPE, MIDDLE EAST & INDIA OTC MULTIVITAMINS & MINERALS SUPPLEMENTS MARKET: COMPETITIVE ANALYSIS
10.1. Recent Developments & Impact Analysis, By Key Market Participants
10.2. Company Categorization
10.3. Participant’s Overview
10.4. Financial Performance
10.5. Product Benchmarking
10.6. Company Market Share Analysis, 2024 (%)
10.7. Company Heat Map Analysis
10.8. Strategy Mapping
10.9. Company Profiles
10.9.1. Amway Corp.
10.9.1.1. Company Overview
10.9.1.2. Financial Performance
10.9.1.3. Product Portfolios
10.9.1.4. Strategic Initiatives
10.9.2. Abbott
10.9.2.1. Company Overview
10.9.2.2. Financial Performance
10.9.2.3. Product Portfolios
10.9.2.4. Strategic Initiatives
10.9.3. Bayer AG
10.9.3.1. Company Overview
10.9.3.2. Financial Performance
10.9.3.3. Product Portfolios
10.9.3.4. Strategic Initiatives
10.9.4. Glanbia PLC
10.9.4.1. Company Overview
10.9.4.2. Financial Performance
10.9.4.3. Product Portfolios
10.9.4.4. Strategic Initiatives
10.9.5. GSK plc.
10.9.5.1. Company Overview
10.9.5.2. Financial Performance
10.9.5.3. Product Portfolios
10.9.5.4. Strategic Initiatives
10.9.6. Herbalife International of America, Inc.
10.9.6.1. Company Overview
10.9.6.2. Financial Performance
10.9.6.3. Product Portfolios
10.9.6.4. Strategic Initiatives
10.9.7. NU SKIN
10.9.7.1. Company Overview
10.9.7.2. Financial Performance
10.9.7.3. Product Portfolios
10.9.7.4. Strategic Initiatives
10.9.8. NOW Foods
10.9.8.1. Company Overview
10.9.8.2. Financial Performance
10.9.8.3. Product Portfolios
10.9.8.4. Strategic Initiatives
10.9.9. Bionova
10.9.9.1. Company Overview
10.9.9.2. Financial Performance
10.9.9.3. Product Portfolios
10.9.9.4. Strategic Initiatives
10.9.10. Bright Lifecare Private Limited
10.9.10.1. Company Overview
10.9.10.2. Financial Performance
10.9.10.3. Product Portfolios
10.9.10.4. Strategic Initiatives
10.9.11. Sun Pharmaceutical Industries Ltd.
10.9.11.1. Company Overview
10.9.11.2. Financial Performance
10.9.11.3. Product Portfolios
10.9.11.4. Strategic Initiatives
10.9.12. Nature's Sunshine Products, Inc.
10.9.12.1. Company Overview
10.9.12.2. Financial Performance
10.9.12.3. Product Portfolios
10.9.12.4. Strategic Initiatives
10.9.13. Nutra Essential OTC (Farmalider)
10.9.13.1. Company Overview
10.9.13.2. Financial Performance
10.9.13.3. Product Portfolios
10.9.13.4. Strategic Initiatives
10.9.14. Nature's Bounty
10.9.14.1. Company Overview
10.9.14.2. Financial Performance
10.9.14.3. Product Portfolios
10.9.14.4. Strategic Initiatives
10.9.15. Arkopharma
10.9.15.1. Company Overview
10.9.15.2. Financial Performance
10.9.15.3. Product Portfolios
10.9.15.4. Strategic Initiatives
